SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-22-000388
Filing Date
2022-05-23
Accepted
2022-05-23 16:09:32
Documents
76
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nptx033122form10q.htm   iXBRL 10-Q 779005
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11925
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11591
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5119
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4997
11 GRAPHIC image_001.jpg GRAPHIC 55972
12 GRAPHIC image_002.jpg GRAPHIC 55621
13 GRAPHIC image_003.jpg GRAPHIC 38470
14 GRAPHIC image_004.jpg GRAPHIC 36697
  Complete submission text file 0001607062-22-000388.txt   4746167

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nptx-20220331.xsd EX-101.SCH 40103
7 XBRL CALCULATION FILE nptx-20220331_cal.xml EX-101.CAL 53686
8 XBRL DEFINITION FILE nptx-20220331_def.xml EX-101.DEF 166898
9 XBRL LABEL FILE nptx-20220331_lab.xml EX-101.LAB 303612
10 XBRL PRESENTATION FILE nptx-20220331_pre.xml EX-101.PRE 260181
70 EXTRACTED XBRL INSTANCE DOCUMENT nptx033122form10q_htm.xml XML 472116
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 858-883-2642
NEUROPATHIX, INC. (Filer) CIK: 0001615999 (see all company filings)

IRS No.: 462645343 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55657 | Film No.: 22951662
SIC: 2834 Pharmaceutical Preparations